Search research articles
Contact Us
Filters
Showing results (31-40 of 134) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2016
HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous Leukemia
Tsung-Huei Lai, Brett Ewald, Alma Zecevic, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 4, 2018
MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function
Nina C Zitzer, Katiri Snyder, Xiamoei Meng, et al.
Blood
|
April 8, 2026
A tumor suppressor role of the miR-15b/16-2 cluster in T-cell acute lymphoblastic leukemia
Maria L Toribio, María J García-León, Marina García-Peydró, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 22, 2012
miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model
Sukhinder K Sandhu, Stefano Volinia, Stefan Costinean, et al.
Leukemia & Lymphoma
|
August 20, 2013
Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia
Alison R Walker, Rebecca B Klisovic, Ramiro Garzon, et al.
Cancers
|
January 10, 2026
Pharmacologic Targeting of miR29b with Bortezomib and Sorafenib to Improve Decitabine Sensitivity in Patients with Acute Myeloid Leukemia: Results from a Phase 1 Dose-Escalation Trial
Shivani Handa, Kristin Koenig, Qiuhong Zhao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2009
Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas
Mehdi Hamadani, Don M Benson, Craig C Hofmeister, et al.
Blood
|
June 9, 2012
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia
Parvathi Ranganathan, Xueyan Yu, Caroline Na, et al.
The Journal of Biological Chemistry
|
June 23, 2019
Correction: Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation
Zhaoyong Li, Mohammad Q Hassan, Mohammed Jafferji, et al.
Experimental Hematology
|
May 20, 2023
Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma
Chinmayee Goda, Sofia Kolovich, Alexander Rudich, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 134) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2016
HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous Leukemia
Tsung-Huei Lai, Brett Ewald, Alma Zecevic, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 4, 2018
MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function
Nina C Zitzer, Katiri Snyder, Xiamoei Meng, et al.
Blood
|
April 8, 2026
A tumor suppressor role of the miR-15b/16-2 cluster in T-cell acute lymphoblastic leukemia
Maria L Toribio, María J García-León, Marina García-Peydró, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 22, 2012
miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model
Sukhinder K Sandhu, Stefano Volinia, Stefan Costinean, et al.
Leukemia & Lymphoma
|
August 20, 2013
Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia
Alison R Walker, Rebecca B Klisovic, Ramiro Garzon, et al.
Cancers
|
January 10, 2026
Pharmacologic Targeting of miR29b with Bortezomib and Sorafenib to Improve Decitabine Sensitivity in Patients with Acute Myeloid Leukemia: Results from a Phase 1 Dose-Escalation Trial
Shivani Handa, Kristin Koenig, Qiuhong Zhao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2009
Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas
Mehdi Hamadani, Don M Benson, Craig C Hofmeister, et al.
Blood
|
June 9, 2012
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia
Parvathi Ranganathan, Xueyan Yu, Caroline Na, et al.
The Journal of Biological Chemistry
|
June 23, 2019
Correction: Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation
Zhaoyong Li, Mohammad Q Hassan, Mohammed Jafferji, et al.
Experimental Hematology
|
May 20, 2023
Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma
Chinmayee Goda, Sofia Kolovich, Alexander Rudich, et al.
Page
of 14